Mutual of America Capital Management LLC Acquires 2,395 Shares of Humana Inc. (NYSE:HUM)

Mutual of America Capital Management LLC increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 12.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,717 shares of the insurance provider's stock after buying an additional 2,395 shares during the period. Mutual of America Capital Management LLC's holdings in Humana were worth $6,879,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Pzena Investment Management LLC lifted its holdings in shares of Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after purchasing an additional 1,955,375 shares during the period. Davis Selected Advisers lifted its stake in Humana by 16.1% in the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider's stock valued at $863,640,000 after buying an additional 321,233 shares during the period. Marshall Wace LLP lifted its stake in Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock valued at $532,564,000 after buying an additional 774,085 shares during the period. Legal & General Group Plc raised its stake in Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider's stock worth $442,396,000 after buying an additional 24,842 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of Humana by 2.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,018,248 shares of the insurance provider's stock worth $380,368,000 after purchasing an additional 20,891 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Price Performance

HUM traded up $4.29 on Tuesday, reaching $275.64. The company had a trading volume of 779,237 shares, compared to its average volume of 1,870,194. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a market cap of $33.19 billion, a price-to-earnings ratio of 24.03, a P/E/G ratio of 2.17 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business has a 50 day simple moving average of $279.91 and a 200 day simple moving average of $331.59.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. As a group, sell-side analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's dividend payout ratio is currently 31.36%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HUM shares. KeyCorp started coverage on shares of Humana in a report on Friday, October 11th. They set a "sector weight" rating for the company. UBS Group decreased their price target on Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, October 4th. Jefferies Financial Group lowered shares of Humana from a "buy" rating to a "hold" rating and dropped their price target for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Wells Fargo & Company decreased their price target on Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. Finally, Truist Financial decreased their target price on Humana from $400.00 to $260.00 and set a "hold" rating for the company in a research report on Friday, October 11th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.